Edit filter log

[ 0 => '{{Infobox company', 1 => '|name = KannaLife Sciences Inc.', 2 => '|logo = [[File:Kannalife-logo.jpg|250px|Corporate logo]]', 3 => '|type = Private', 4 => '|slogan =', 5 => '|foundation = 2010', 6 => '|founders = Dean Petkanas, [[Thoma Kikis]]', 7 => '|location = [[Doylestown, Pennsylvania]] And [[Huntington, New York]] ', 8 => '|area_served = ', 9 => '|industry = [[Pharmaceutical industry|Pharmaceutical]]', 10 => '|revenue = ', 11 => '|net_income = ', 12 => '|assets = Exclusive License of patent {{patent|US|6630507}}', 13 => '|equity = ', 14 => '|homepage = [http://kannalife.com/ http://kannalife.com]', 15 => '}}', 16 => false, 17 => '[[File:US-patent-6630507.pdf|thumb|right|KannaLife was granted the Exclusive License by NIH-OTT for the commercialization of patent {{patent|US|6630507}} “Cannabinoids as Antioxidants and Neuroprotectants."]]', 18 => false, 19 => ''''Kannalife Sciences Inc.''' is a bio-pharmaceutical and phyto-medical company based in Huntington, NY and [[Doylestown, Pennsylvania]] founded by Dean Petkanas and [[Thoma Kikis]].<ref>{{cite web|url=https://news.vice.com/article/the-nfls-anti-weed-policy-even-extends-to-drugs-that-could-prevent-brain-damage. |title=The NFL's Anti-Weed Policy Even Extends to Drugs That Could Prevent Brain Damage |last=Guion |first=Payton |date=November 12, 2014 |work=VICE News |accessdate=2014-12-12}}</ref> Kannalife was formed in 2010 and is involved in the research and development of novel new therapeutic agents designed to reduce oxidative stress, and act as immuno-modulators and neuroprotectants. It is a portfolio company of [[Medical Marijuana, Inc.]].<ref name="nyt1">{{cite web|url=https://www.nytimes.com/2014/11/02/nyregion/a-competition-to-get-a-medical-marijuana-license-in-new-york.html?_r=0|title=For Pot Inc., the Rush to Cash In Is Underway|last=Leland|first=John|date=October 31, 2014|work=The New York Times|accessdate=2014-10-31}}</ref>', 20 => false, 21 => 'In 2011, the company was granted an Exclusive License<ref>{{cite web|url=https://www.federalregister.gov/articles/2011/11/17/2011-29726/prospective-grant-of-exclusive-license-development-of-cannabinoids-and-cannabidiols-based |title=Prospective Grant of Exclusive License: Development of Cannabinoid(s) and Cannabidiol(s) Based Therapeutics To Treat Hepatic Encephalopathy in Humans. |publisher=federalregister.gov |date= |accessdate=2011-11-17}}</ref> by [[National Institutes of Health]] – Office of Technology Transfer ([[NIH Office of Technology Transfer|NIH-OTT]]) for the Commercialization of patent {{patent|US|6630507}}, “Cannabinoids as Antioxidants and Neuroprotectants."<ref>{{cite web|url=http://www.thestreet.com/story/11609018/1/kannalife-sciences-inc-signs-exclusive-license-agreement-with-national-institutes-of-health-office-of-technology-transfer-nih-ott.html |title=Kannalife Sciences, Inc. Signs Exclusive License Agreement With National Institutes Of Health Office Of Technology Transfer (NIH-OTT) |publisher=thestreet.com |date= |accessdate=2012-07-09}}</ref>', 22 => false, 23 => 'Kannalife is currently conducting research and development at the [[Pennsylvania Biotechnology Center of Bucks County]]<ref>{{cite web|url=http://www.genengnews.com/gen-news-highlights/kannalife-in-r-amp-d-collaboration-for-cannabinoid-based-drugs/81248179/ |title=Kannalife in R&D Collaboration for Cannabinoid-Based Drugs |publisher=Genengnews.com |date= |accessdate=2013-04-04}}</ref> in Doylestown, PA, for a target drug candidate, [[KLS-13019]]<ref name=Kinney-2016>{{cite journal|author1=William A. Kinney |author2=Mark E. McDonnell |author3=Hua Marlon Zhong |author4=Chaomin Liu |author5=Lanyi Yang |author6=Wei Ling |author7=Tao Qian |author8=Yu Chen |author9=Zhijie Cai |author10=Dean Petkanas |author11=Douglas E. Brenneman |title=Discovery of KLS-13019, a Cannabidiol-Derived Neuroprotective Agent, with Improved Potency, Safety, and Permeability|journal=ACS Med. Chem. Lett.|doi=10.1021/acsmedchemlett.6b00009}}</ref> to treat [[Hepatic encephalopathy]] and [[Chronic traumatic encephalopathy|CTE]],<ref>{{cite web|url=http://www.foxnews.com/health/2014/11/10/medical-marijuana-company-developing-drug-to-protect-nfl-players-brains/ |title=Medical marijuana company developing drug to protect NFL players’ brains |last=Mulvihill Moran |first=Jessica |date=November 9, 2014 |work=Fox News |accessdate=2014-11-09}}</ref> an oxidative stress related disease that affects the cognitive and behavioral functions, and the wellness of the brain.', 24 => false, 25 => 'Kannalife was featured in [[Sports Illustrated]] article on using cannabinoids to treat [[chronic traumatic encephalopathy|CTE]]. <ref>{{cite web|url=http://www.si.com/nfl/2016/07/12/cannabis-cte-treatment-kannalife |title=How cannabis is helping one company research treatment of CTE |date=July 12, 2016|work=Sports Illustrated}}</ref> ', 26 => false, 27 => '==References==', 28 => '{{Reflist}}', 29 => false, 30 => '[[Category:Health care companies established in 2010]]', 31 => '[[Category:Health care companies based in Pennsylvania]]', 32 => '[[Category:Companies based in Bucks County, Pennsylvania]]', 33 => '[[Category:Pharmaceutical companies of the United States]]', 34 => '[[Category:Cannabis research]]', 35 => '[[Category:American companies established in 2010]]', 36 => '[[category:2010 in cannabis]]' ]